John Johnson
Director · 3 filings · Latest: Jun 4, 2026
Axogen, Inc.
Verastem, Inc.
Xeris Biopharma Holdings, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
XERS | John Johnson | Director | Jun 4, 2026 | Sale | $6.09 | 15,000 | $91.4K | 683,083 | |
AXGN | John Johnson | Director | May 7, 2026 | Sale | $43.26 | 11,050 | $478.0K | 0 | |
AXGN | John Johnson | Director | May 7, 2026 | Option Exercise | $7.04 | 11,050 | $77.8K | 11,050 | |